Literature DB >> 11559706

Defective Gi protein coupling in two formyl peptide receptor mutants associated with localized juvenile periodontitis.

R Seifert1, K Wenzel-Seifert.   

Abstract

The formyl peptide receptor (FPR) is a prototypical chemoattractant receptor expressed in neutrophils. It is well known that the FPR couples to G(i) proteins to activate phospholipase C, chemotaxis, and cytotoxic cell functions, but the in vivo role of the FPR in man has remained elusive. Recently, F110S and C126W mutations of the FPR have been associated with localized juvenile periodontitis. We studied FPR-F110S and FPR-C126W in comparison with wild-type FPR (FPR-WT) by coexpressing epitope-tagged versions of these receptors with the G protein Galpha(i2)beta(1)gamma(2) in Sf9 insect cells. FPRs were efficiently expressed in Sf9 membranes as assessed by immunoblotting using the beta(2)-adrenoreceptor as a standard. FPR-C126W differed from FPR-WT and FPR-F110S in migration on SDS-polyacrylamide gels and tunicamycin-sensitive glycosylation. FPR-WT efficiently reconstituted high-affinity agonist binding and agonist- and inverse agonist-regulated guanosine 5'-O-(3-thiotriphosphate) (GTPgammaS) binding to Galpha(i2)beta(1)gamma(2). In contrast, FPR-F110S only weakly reconstituted agonist-stimulated GTPgammaS binding, and FPR-C126W was completely inefficient. Collectively, our data show almost complete and complete loss of G(i) protein coupling in FPR-F110S and FPR-C126W, respectively. The severe functional defects in FPR-F110S and FPR-C126W contrast with the discrete clinical symptoms associated with these mutations, indicating that loss of FPR function in host defense is, for the most part, readily compensated.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11559706     DOI: 10.1074/jbc.M106621200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Functional differences between human formyl peptide receptor isoforms 26, 98, and G6.

Authors:  Katharina Wenzel-Seifert; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-04-05       Impact factor: 3.000

2.  The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis.

Authors:  N Prevete; F Liotti; C Visciano; G Marone; R M Melillo; A de Paulis
Journal:  Oncogene       Date:  2014-09-29       Impact factor: 9.867

Review 3.  Enemy attraction: bacterial agonists for leukocyte chemotaxis receptors.

Authors:  Dominik Alexander Bloes; Dorothee Kretschmer; Andreas Peschel
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

4.  Formyl peptide receptor 1 suppresses gastric cancer angiogenesis and growth by exploiting inflammation resolution pathways.

Authors:  Nella Prevete; Federica Liotti; Anna Illiano; Angela Amoresano; Piero Pucci; Amato de Paulis; Rosa Marina Melillo
Journal:  Oncoimmunology       Date:  2017-02-21       Impact factor: 8.110

Review 5.  International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family.

Authors:  Richard D Ye; François Boulay; Ji Ming Wang; Claes Dahlgren; Craig Gerard; Marc Parmentier; Charles N Serhan; Philip M Murphy
Journal:  Pharmacol Rev       Date:  2009-06-04       Impact factor: 25.468

6.  Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: a new approach to antimicrobial chemotherapy.

Authors:  Huamei Fu; Claes Dahlgren; Johan Bylund
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

7.  Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis.

Authors:  Michael J Molloy; John R Grainger; Nicolas Bouladoux; Timothy W Hand; Lily Y Koo; Shruti Naik; Mariam Quinones; Amiran K Dzutsev; Ji-Liang Gao; Giorgio Trinchieri; Philip M Murphy; Yasmine Belkaid
Journal:  Cell Host Microbe       Date:  2013-09-11       Impact factor: 21.023

8.  The two neutrophil members of the formylpeptide receptor family activate the NADPH-oxidase through signals that differ in sensitivity to a gelsolin derived phosphoinositide-binding peptide.

Authors:  Huamei Fu; Lena Björkman; Paul Janmey; Anna Karlsson; Jennie Karlsson; Charlotta Movitz; Claes Dahlgren
Journal:  BMC Cell Biol       Date:  2004-12-29       Impact factor: 4.241

Review 9.  Formyl-Peptide Receptor Agonists and Amorphous SiO2-NPs Synergistically and Selectively Increase the Inflammatory Responses of Human Monocytes and PMNs.

Authors:  Regina Tavano; Daniela Segat; Chiara Fedeli; Giulia Malachin; Elisa Lubian; Fabrizio Mancin; Emanuele Papini
Journal:  Nanobiomedicine (Rij)       Date:  2016-01-01

Review 10.  Formyl peptide receptors in the mucosal immune system.

Authors:  Yu Sun Jeong; Yoe-Sik Bae
Journal:  Exp Mol Med       Date:  2020-10-20       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.